Equities

USANA Health Sciences Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

USANA Health Sciences Inc

Actions
Consumer Staples Food Producers
  • Price (USD)32.77
  • Today's Change0.32 / 0.99%
  • Shares traded55.64k
  • 1 Year change-27.13%
  • Beta0.6082
Data delayed at least 15 minutes, as of Jul 03 2025 18:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

USANA Health Sciences, Inc. and subsidiaries is a global nutrition, personal health and wellness company that develops and manufactures science-based nutritional and personal care products. Its segments include Direct selling and Hiya direct-to-consumer. The Direct Selling segment develops and manufactures science-based nutritional, personal care and skincare products with a primary focus on promoting long-term health and wellness in various geographic markets worldwide that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children’s health and wellness products in the United States that are distributed through the direct-to-consumer channel. Its product line includes USANA Nutritionals Optimizers, Essentials/CellSentials, and Foods. USANA Nutritionals Optimizers products include Proflavanol, CoQuinone 30, and BiOmega-3. Essentials/CellSentials products include USANA CellSentials and HealthPak 100.

  • Revenue in USD (TTM)876.24m
  • Net income in USD34.90m
  • Incorporated1992
  • Employees1.70k
  • Location
    USANA Health Sciences Inc3838 West Parkway Blvd.SALT LAKE CITY 84120-6336United StatesUSA
  • Phone+1 (801) 954-7100
  • Fax+1 (801) 956-9486
  • Websitehttps://www.usana.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
USNA:NYQ since
announced
Transaction
value
Hiya Health Products LLCDeal completed23 Dec 202423 Dec 2024Deal completed-1.83%205.00m
Data delayed at least 15 minutes, as of Jul 03 2025 18:00 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Mama's Creations Inc128.75m4.40m338.12m305.0081.0612.7943.452.630.11090.11093.250.70312.5823.4518.55422,114.808.7910.7614.0116.3824.3924.993.414.021.0120.150.18660.0019.4129.59-43.0119.3580.20--
BRC Inc383.07m-6.39m343.09m551.00--30.33--0.8956-0.0833-0.08335.170.05241.704.5914.80695,230.50-7.71-55.38-15.98-122.3839.5436.68-4.53-27.730.60750.3550.6089---1.0436.6682.37--50.94--
B&G Foods Inc1.88bn-210.18m359.89m2.78k--0.7014--0.1912-2.66-2.6623.716.430.59632.7513.72676,233.10-6.66-0.696-7.20-0.74821.4121.66-11.16-1.231.071.320.7963---6.303.08-279.48---8.15-11.81
Lifeway Foods Inc188.28m10.14m388.29m291.0038.465.2428.412.060.6640.66412.424.882.1316.1411.86647,000.0011.497.8013.979.4625.5324.445.393.922.33174.440.00--16.6714.81-20.6081.9241.56--
Calavo Growers Inc694.49m14.18m490.34m2.11k34.612.3922.120.7060.79440.581938.9411.491.9015.0112.21329,765.403.93-0.54985.68-0.730710.118.032.07-0.26471.546.130.0223--11.35-11.1745.34-28.61-29.61-12.94
Westrock Coffee Co872.02m-83.50m606.65m1.41k--8.49--0.6957-0.9081-0.90819.553.650.82194.4310.04619,333.80-7.89---10.51--16.69---9.60--0.5701-0.91230.6251---1.62---130.12------
Microalliance Group Inc22.88m9.82m609.32m30.0073.9119.9561.1926.630.01350.01350.03250.05010.76310.486912.65762,790.3032.74--35.89--68.46--42.90--12.67--0.00--3,030.68--3,074.43------
USANA Health Sciences Inc876.24m34.90m610.28m1.70k17.951.169.810.69651.831.8345.8628.201.272.54--515,436.505.0613.526.5017.9280.5381.183.978.171.51--0.03790.00-7.22-4.23-34.11-16.0066.72--
Seneca Foods Corp1.58bn41.16m736.96m2.89k18.091.168.580.46685.895.89226.2391.681.231.9417.82547,274.503.215.213.756.129.5111.032.613.870.7072.340.37840.008.253.40-34.91-4.18-10.74--
John B Sanfilippo & Son Inc1.11bn55.42m777.37m1.80k13.982.249.500.70184.734.7394.5629.482.053.8614.75615,412.3010.2414.0114.0718.6018.4820.715.006.270.525328.050.218883.846.714.01-4.158.8313.437.78
Kuber Resources Corp8.83m2.48m819.30m16.00337.2234.28244.3892.770.01540.01540.06370.15170.4387--1.73--12.30--17.17--72.01--28.03--1.34916.470.0344--74.29---68.29------
Data as of Jul 03 2025. Currency figures normalised to USANA Health Sciences Inc's reporting currency: US Dollar USD

Institutional shareholders

38.42%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 31 Mar 20251.62m8.50%
The Vanguard Group, Inc.as of 31 Mar 20251.33m6.96%
Pzena Investment Management LLCas of 31 Mar 20251.10m5.75%
Renaissance Technologies LLCas of 31 Mar 20251.09m5.69%
Dimensional Fund Advisors LPas of 31 Mar 2025805.89k4.23%
SSgA Funds Management, Inc.as of 31 Mar 2025451.37k2.37%
Geode Capital Management LLCas of 31 Mar 2025320.25k1.68%
American Century Investment Management, Inc.as of 31 Mar 2025255.24k1.34%
Jacobs Levy Equity Management, Inc.as of 31 Mar 2025188.51k0.99%
Charles Schwab Investment Management, Inc.as of 31 Mar 2025174.00k0.91%
More ▼
Data from 31 Mar 2025 - 31 Mar 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.